Variation in management of small invasive breast cancers detected on screening in the former South East Thames region: Observational study

British Medical Journal

Volumn 315, Issue 7118, 1997, Pages 1266-1272

  Moritz, S ^a   Bates, T ^a   Henclerson, S M ^b   Humphreys, S ^a   Michcll, M J ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b WILLIAM HARVEY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER REGISTRY; CANCER SCREENING; CANCER SURGERY; CLINICAL PROTOCOL; DATA BASE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; UNITED KINGDOM;

EID: 0030668845     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7118.1266     Document Type: Article

References (38)

1. Departmem of Health. Population health outcome indicators 1993. London: HMSO.1993.
2. Bcrrino F, Sant M, 'erdccchia A, Capocaccia R, Hakulincn T, Esic ej, eds. Sun-real of cancer patients in Europe. TJie Eurocare stuffy. Lyons: International Agency for Research on Cancer, 1995. (IARC scientific publication No 132.)
3. Saiiubury R, I laward B, Rider Ljolmsion C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995;3t5:12G5-70
4. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: a study of 378G patients in die west of Scotland. BMJ 1996;312:145-8.
5. Baum M. Specialist surgeons and survival in breast cancer. Large differences in survival are not explained. BMJ 199G;312:1155.
6. McCarthy M, Bore J. Treatment of breast cancer in two teaching hospitals: a comparison with consensus guidelines. EurJ Cancer 1991 ;2S:579-82.
7. Basnett I, Gill M, Tobias JS. Variadons in breast cancer management between a teaching and a non-teadiîng district EurJ Cancer 1992;2SA: 1915-50.
8. Ansell D, Whitman S, Lipton R, Cooper R. Race, income and sunival from breast cancer at two public hospitals. Cancer 1993;72:2974-8.
9. Morris J. Regional variation in the surgical treatment of early breast cancer.BrJSurg 1992;79:1312-3.
10. Naltinger AB, Gottlieb MS, Veum J, Yahnke D, GoodwinJS. Geographic variation in the use of breast-conserving treatment for breast cancer. A' Engt J Med 1992:326:1102-7.
11. Iscoe NA, Goel V, Wu K, Fehringer G, I lolowaty EJ, Na) lor Cn Variation in breast cancer surgery in Ontario. Can Med Assoc J 1994:150:345-52.
12. Campbell I, Royle G, Coddington R, Herbert A, Rubin C,Taylor I, et al. Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme. Ann R Coll Surg Engl 1993;75:13-7.
13. Baak JPA, Wisse-Brekelmans ECM, Kurver PHJ, Gorp LHM, Voorhorst FJ, Miettinen OS. Regional differences in breast cancer survival are correlated with differences in differentiation and rate of proliferation. Hum Pathol 1992;23:9S9-92.
14. Moss SM, Ellman R,Coleman D, Chamberlain J. Survival of patients with breast cancer diagnosed in the United Kingdom trial of early detection of breast cancerj Med Screening 1994; 1:193-8.
15. Chouillet AM, Bell CMJ, Hiscox JG. Management of breast cancer in southeast England. H.MJ 1991:308:168-71.
16. Fisher B, Anderson S, Rcdmond CK, Wolmark N, Wickerman DI, Cronin WM. Rcanalysis and results after 12 years of follow-up in a randomised clinical trial comparing total mastectomy and lumpcctomy with or without irradiation in the treatment of breast cancer. NEnglJMed 1995:333:1456-61.
17. Vcronesi V, Banfi A, Salvadori B, Luini A, Saccozzi R, Zucali R, et al. Breast conservation is the treatment of choice in small breast cancer: longterm results of a randomised trial, t'.urj Cancer 1990:26:668-70.
18. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in eaily breast cancer. An overview of the randomised trials. XKnglJMed 1995:333:14 11-55.
19. Van Dongen J, Bartelink 11, Fentiman I, Lerut T, Mignolct F, Olthuis G, et al. Factors influencing local relapse and survival and results of salvage treatment after breast conserving therapy in operable breast cancer: EORTC Trial 10S01. breast conservation compared with mastectomy in TNM stage I and II breast cancer. F.urJ Cancer 1992;28A:S01-5. f
20. National Coordination Group for Surgeons Woiking in Breast Cancer Screening. Quality assurance guidelines for surgeons in breast cancer screening. Sheffield: BUS Breast Screening Programme, 1996. (N1IS BSP publication No 20.)
21. Uljegrcn G, Holmbcrg I, Adami II, Wcstman G, Graffman S, Bcrgh J, Uppsala-Orebro Breast Cancer Study Groujx Sector resection with or without postoperative radiodierapy for stage I breast cancer: five year results of a randomised trialJAM Cancer liai 1994:86:717-22.
22. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy; 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet I992;339:l-15.
23. Early Breast Cancer Trialists' Collaborative Grouri Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy; 133 randomised trials involving 31000 recurrences and 24000 deaths among 75 000 women. Larurt 1992;339:71-84.
24. Blarney RW Wilson ARM, PatnickJ, Dixon JM. Screening for breast cancer. DMJ 1994;309:I076-9.
25. BcllJ, Chnuillct AM. Management of breast cancer. BMJ 1994:308:1508.
26. British Association of Surgical Oncology Breast Group. BASOII'trial: protocol of a randomised trial for the management of small well-differentiated and special typt carcinomas of the breast. London: BASO, 1992. (Revised 1993.)
27. Dixon JM, Ravisekar O, Cunningliam M, Anderson EDC, Anderson TJ, Broun I IK. Factors affecting outcome of patients with impalpable breast cancer detected by breast screening. Br J Surg 1990:83:997-1001.
28. AyanianJZ, Guadagrosi E. Variations in breast cancer treament by patient and prouder characteristics. Breast Cancer Res Treat 199G;40:G5-74.
29. Harries SA, Scrivener R, Lawrence RX, Fieldman NR, Kissin MW, Bates T Woikload of surgeons involved in die treatment of breast cancer. Breast 1997;G:21-5.
30. Gelber RD, Goldhirsch A. Radiotherapy to die conserved breast: is it avoidable if the cancer is small? J Natl Cancer bist 1994;SG:652-4.
31. Clark RM, McCulloch PB, Levine MX, Lipa M, Wilkinson RH, Mahoney LJ, et al. Randomised clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node negative breast cancer Instart Cancer Inst 1992;84:683-9.
32. Dixon JM. Surgery and radiodierapy for early breast cancer. D.MJ 1995;311:151-0.
33. Schnitt SJ, I layman J, Gelman R, Eberlein TJ, Love SM, Mayzel K, et al. A prospective study of conservative surgery alone in the treatment of selected patients widi stage 1 breast cancer. Cancer 199G;77:1094-100.
34. Fentiman IS, ' Mansell RE. The axilla: not a no-go-zone. Lancet 1991037:221-3.
35. Sacks NTM, Barr LC, Allan SM, Baum M. The role of axillary dissection in operablebreat cancer. Breast 1992:1:41-9.
36. Richards MA, Wolfe CDA, Tilling K, Barton J. Bourne 11M, Gregory WM. Variations in die management and survival of women under 50 years widi breast cancer in die South East Thames Region. Dr J Cancer 1990:73:751-7.
37. Varnold JR, Bliss JM, Brunt M, Earl II, Kaye S, Mason M, et al. Management of breast cancer; refer women to- muliidisciplinary clinics. BMJ 1991:308:714-5.
38. Department of Healdi. A policy frame u-orkfor commissioning cancer sendees. London: DoH, 1991.